American Society of Hematology

Editors of Blood Select Top 10 Manuscripts from 2016

Studies Include Advancements in Chimeric Antigen Receptor T Cells, Gene Therapy, and Genetic Sequencing

(WASHINGTON, December 21, 2016) — This year, there have been more than 1,000 manuscripts published in Blood, the Journal of the American Society of Hematology. To recognize these achievements, Blood Editor-in-Chief Bob Löwenberg, MD, PhD, and Deputy Editor Nancy Berliner, MD, have selected the top 10 most outstanding manuscripts of 2016.

“From harnessing the immune system to target untreatable diseases to honing cutting-edge genome editing techniques to correct genetic defects, the promise of cures for many diseases starts with a better understanding of the blood,” said Dr. Löwenberg. “Recognizing hematology as the home of some of science’s most groundbreaking advances, and Blood’s role as the top-cited journal of our field, we are proud to look back at the top papers of 2016.”

To identify the following top manuscripts of the year, the editors considered quality of the work and interest to the field of hematology, judged by how often the paper was accessed or cited. The following articles are listed in no particular order.


Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field of hematology, is available weekly in print and online. Blood is the flagship journal of the American Society of Hematology (ASH) (www.hematology.org), the world’s largest professional society concerned with the causes and treatment of blood disorders.

ASH’s mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems by promoting research, clinical care, education, training, and advocacy in hematology.

blood® is a registered trademark of the American Society of Hematology.

 

CONTACT: 
Stephen Fitzmaurice, American Society of Hematology 
sfitzmaurice@hematology.org; 202-552-4927 

back to top